Por favor, tente outra pesquisa
Nome | Idade | Desde | Título |
---|---|---|---|
Douglass B. Given | 69 | 2010 | Chairman of the Board |
Christopher R. Anzalone | 52 | 2007 | CEO, President & Director |
Robert G. Gish | - | - | Chairman of Hepatitis B Clinical Advisory Board |
William D. Waddill | 65 | 2018 | Independent Director |
Michael S. Perry | 64 | 2011 | Independent Lead Director |
Mauro Ferrari | 64 | 2008 | Independent Director |
Carlo Ferrari | - | - | Member of Hepatitis B Clinical Advisory Board |
Stephen Alister Locarnini | - | - | Member of Hepatitis B Clinical Advisory Board |
Ching-Lung Lai | - | - | Member of Hepatitis B Clinical Advisory Board |
Jeffrey H. Teckman | - | - | Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board |
Johnson Y. N. Lau | - | - | Member of Hepatitis B Clinical Advisory Board |
James K. Stoller | - | - | Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board |
Rohit Loomba | - | - | Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board |
Victoria M. Vakiener | 59 | 2022 | Independent Director |
Adeoye Y. Olukotun | 78 | 2020 | Independent Director |
Mark M. Davis | - | - | Founder and Founder & Director of Insert Therapeutics Inc & Calando |
Hongbo Lu | 52 | 2024 | Independent Director |
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou deste comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão